
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Socio‐economic association of alcohol use disorder and cardiovascular and alcohol‐associated liver disease from 2010 to 2019
Pojsakorn Danpanichkul, Vincent Chen, Nathorn Chaiyakunapruk, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 3, pp. 340-349
Closed Access | Times Cited: 16
Pojsakorn Danpanichkul, Vincent Chen, Nathorn Chaiyakunapruk, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 3, pp. 340-349
Closed Access | Times Cited: 16
Showing 16 citing articles:
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019
Pojsakorn Danpanichkul, Kanokphong Suparan, Priyata Dutta, et al.
Metabolism (2024) Vol. 158, pp. 155958-155958
Closed Access | Times Cited: 28
Pojsakorn Danpanichkul, Kanokphong Suparan, Priyata Dutta, et al.
Metabolism (2024) Vol. 158, pp. 155958-155958
Closed Access | Times Cited: 28
Alcohol–Related Liver Disease, Followed by Metabolic Dysfunction–Associated Steatotic Liver Disease, Emerges as the Fastest‐Growing Aetiologies for Primary Liver Cancer in the United States
Pojsakorn Danpanichkul, Kwanjit Duangsonk, Markos Kalligeros, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 4
Pojsakorn Danpanichkul, Kwanjit Duangsonk, Markos Kalligeros, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 4
Global Epidemiology of Alcohol-Related Liver Disease, Liver Cancer, and Alcohol Use Disorder, 2000–2021
Pojsakorn Danpanichkul, Luis Antonio Díaz, Kanokphong Suparan, et al.
Clinical and Molecular Hepatology (2025)
Open Access | Times Cited: 3
Pojsakorn Danpanichkul, Luis Antonio Díaz, Kanokphong Suparan, et al.
Clinical and Molecular Hepatology (2025)
Open Access | Times Cited: 3
Mortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake
Majd B. Aboona, Pojsakorn Danpanichkul, Vincent Chen, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 11, pp. 2456-2463
Closed Access | Times Cited: 8
Majd B. Aboona, Pojsakorn Danpanichkul, Vincent Chen, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 11, pp. 2456-2463
Closed Access | Times Cited: 8
Increased MASH-associated liver cancer in younger demographics
Pojsakorn Danpanichkul, Yanfang Pang, Kanokphong Suparan, et al.
Hepatology Communications (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Pojsakorn Danpanichkul, Yanfang Pang, Kanokphong Suparan, et al.
Hepatology Communications (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Impact of GLP ‐1 Receptor Agonists on Alcohol‐Related Liver Disease Development and Progression in Alcohol Use Disorder
Chia‐Chih Kuo, Chun‐Hsien Li, Min‐Hsiang Chuang, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 1
Chia‐Chih Kuo, Chun‐Hsien Li, Min‐Hsiang Chuang, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 1
Global burden and cross-country health inequalities of early-onset colorectal cancer and its risk factors from 1990 to 2021 and its projection until 2036
Jinhai Zhang, Dehua Ou, Aosi Xie, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Jinhai Zhang, Dehua Ou, Aosi Xie, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Mortality of gastrointestinal cancers attributable to smoking, alcohol, and metabolic risk factors, and its association with socioeconomic development status 2000–2021
Pojsakorn Danpanichkul, Kanokphong Suparan, Yanfang Pang, et al.
The American Journal of Medicine (2025)
Closed Access
Pojsakorn Danpanichkul, Kanokphong Suparan, Yanfang Pang, et al.
The American Journal of Medicine (2025)
Closed Access
The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021
Ethan Kai Jun Tham, Darren Jun Hao Tan, Pojsakorn Danpanichkul, et al.
Liver International (2025) Vol. 45, Iss. 3
Open Access
Ethan Kai Jun Tham, Darren Jun Hao Tan, Pojsakorn Danpanichkul, et al.
Liver International (2025) Vol. 45, Iss. 3
Open Access
Global, regional and country burden of high BMI-related liver cancer among individuals aged above 70: trends from 1990 to 2021 and projections to 2044
Ke‐Jie He, Wensheng Shu, Yanggang Hong
Frontiers in Public Health (2025) Vol. 13
Open Access
Ke‐Jie He, Wensheng Shu, Yanggang Hong
Frontiers in Public Health (2025) Vol. 13
Open Access
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Soo Young Hwang, Pojsakorn Danpanichkul, Vatche G. Agopian, et al.
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 4
Soo Young Hwang, Pojsakorn Danpanichkul, Vatche G. Agopian, et al.
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 4
Letter: Optimising public health policies to combat alcohol‐associated liver disease in youth—Authors' reply
Pojsakorn Danpanichkul, Primrose Tothanarungroj, Luis Antonio Díaz, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 8, pp. 1156-1157
Closed Access | Times Cited: 2
Pojsakorn Danpanichkul, Primrose Tothanarungroj, Luis Antonio Díaz, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 8, pp. 1156-1157
Closed Access | Times Cited: 2
Letter: The Essential Role of Social Workers in Reducing Socioeconomic Disparities in Chronic Liver Disease
Qiong Yi, G. Alan Wang, Zongxiang Yue
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 11-12, pp. 1654-1655
Open Access | Times Cited: 2
Qiong Yi, G. Alan Wang, Zongxiang Yue
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 11-12, pp. 1654-1655
Open Access | Times Cited: 2
Integrating behavioral interventions into a holistic approach to metabolic dysfunction-associated steatotic liver disease
Riccardo Righetti, Felice Cinque, Maria Teresa Volpe, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 7, pp. 303-313
Closed Access
Riccardo Righetti, Felice Cinque, Maria Teresa Volpe, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 7, pp. 303-313
Closed Access
Alcohol-related liver and extrahepatic malignancies: burden of disease and socioeconomic disparities in 2019
Pojsakorn Danpanichkul, Kanokphong Suparan, Nathorn Chaiyakunapruk, et al.
European Journal of Gastroenterology & Hepatology (2024)
Closed Access
Pojsakorn Danpanichkul, Kanokphong Suparan, Nathorn Chaiyakunapruk, et al.
European Journal of Gastroenterology & Hepatology (2024)
Closed Access
FGF21 responses to alcohol, an insight from a comparative study in individuals with alcohol use disorder
Suthat Liangpunsakul, Lorenzo Leggio
Alcohol (2024) Vol. 122, pp. 11-13
Closed Access
Suthat Liangpunsakul, Lorenzo Leggio
Alcohol (2024) Vol. 122, pp. 11-13
Closed Access